Wearable Injectors Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Wearable Injectors Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Wearable Injectors Market Research
Report The latest report by IMARC, titled
Wearable Injectors Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 finds that the global
wearable injectors market size reached US 6.6
Billion in 2022. Wearable injectors (WIs) or
patch pumps are drug delivery devices utilized
for the single-step administration of medicines
for longer durations. They automatically deliver
preset doses to patients at optimal times. They
are temporarily attached to the skin to deliver
viscous drugs in large volumes faster and safely
through the subcutaneous tissues in the body.
They comprise a cannula for substance delivery
to tissues, a reservoir to store medicine, and a
drive system to provide the appropriate drug
volume. In addition, these devices are
user-friendly, disposable, and cause minimal
discomfort and pain compared to traditionally
used syringes and vials. As a result, wearable
injectors are extensively used for the treatment
of diabetes, rheumatoid arthritis, cancer, and
cardiovascular diseases. Request Free Sample
Report https//www.imarcgroup.com/wearable-inject
ors-market/requestsample
4
Report Description and Highlights
Report Description

Global Wearable Injectors Market Trends The
market is primarily driven by the increasing
prevalence of chronic medical illnesses such as
neurological, oncological, and autoimmune
disorders. In addition, the rising geriatric
population, which is more susceptible to such
ailments, and the escalating demand for minimally
invasive (MI) treatment alternatives among the
patients represent other major growth-inducing
factors. Moreover, the sudden outbreak of the
coronavirus disease (COVID-19) pandemic prompted
the entire healthcare system to switch to
home-based therapies to stop the spread of the
sickness. This, coupled with the growing
popularity of at-home and self-administrable
injectors to effectively manage disorders with
the minutest risks of inaccurate dosage and
needle stick injuries, is providing a positive
thrust to the market growth. Besides this,
various product innovations, such as the
incorporation of wireless connectivity, passive
warning systems, and Bluetooth technologies with
the injectors, are anticipated to propel the
market growth. These technologies promote
convenient monitoring of the patient through a
smartphone application and offer timely reminders
for dosages. Furthermore, extensive research and
development (RD) activities, along with
significant improvements in the healthcare
infrastructure, are creating a positive market
outlook. Looking forward, IMARC Group expects the
market value to reach US 15.6 Billion by 2028,
exhibiting a CAGR of 14.8 during the forecast
period (2023-2028). Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Type On-bod
y Off-body Breakup by Technology
Spring-based Motor-driven
Rotary Pump Expanding Battery
Others Breakup by Application Oncolog
y Infectious Diseases Cardiova
scular Diseases Autoimmune Diseases
Others

6
Report Description and Highlights
Report Description
Breakup by End Use Hospitals and
Clinics Home Care Others Brea
kup by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Australia
Indonesia Other
s Europe Germany

7
Report Description and Highlights
Report Description
France United
Kingdom Italy
Spain Russia O
thers Latin America Br
azil Mexico Ot
hers Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Becton Dickinson and Company CeQur SA Debiotech SA
  Dexcom Inc. Enable Injections Inc. Gerresheimer
  AG Insulet Corporation Tandem Diabetes Care Inc. W
  est Pharmaceutical Services Inc. Ypsomed AG
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/wearable-injectors-mark
  et

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us